Laser breakthrough heals severe ailments at the speed of light

(NC)—Once considered nothing more than a fancy light show, Low Level Laser Therapy (LLLT) has gained acceptance in recent years as an alternative or compliment to conventional medical treatments.

And with the support of Ontario Centres of Excellence (OCE), a Toronto-based company is quickly becoming a recognized leader in laser therapy, showing the province as well as North America the extent to which light can be harnessed to heal tissue.

Theralase Inc. has collaborated with OCE and the University Health Network (UHN) for over a decade to develop its line of LLLT products that are used in hospitals and medical clinics across Canada and the US.

Designed to treat wounds, anti-inflammation and pain relief, Theralase is the creator of one of only three FDA approved therapeutic medical lasers licensed in the US, and the only therapeutic laser system approved for chronic knee pain.

Theralase's lasers penetrate the skin's surface and accelerate cell growth and reproduction, stimulate tissue repair for faster healing, reduce the formation of scar tissue, reduce swelling caused by bruising or inflammation and increase blood flow to damaged areas. This is accomplished with no heating effect, no damage to the skin and no known side effects.

Currently, the company's lasers ease the pain associated with carpal tunnel syndrome, knee and shoulder injuries, as well as rheumatoid arthritis, osteoarthritis and diabetic foot ulcers. Back pain sufferers with conditions such as bursitis and sciatica are also finding relief.

Backing Theralase's work is a steady stream of compelling medical studies proving its effectiveness. “Ten years ago, LLLT was more imagination than substance to the North American market,” said Roger Dumoulin-White, president of Theralase. “Today it's a proven technology and its applications continue to expand.”

- News Canada